Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Innovative Trials

    Website
    Email
    +44 (0) 1707 378 581

    Innovative Trials is a prominent international company specializing in patient recruitment and retention for clinical trials. Boasting 15 years of experience, Innovative Trials provides three fundamental services in this domain:

    • 1:1 In-country Recruitment Coaching & Site Support, facilitated by in-country patient recruitment experts operating in more than 70 countries,
    • Site & Patients Educational Materials,
    • Navigator, a patient support center for referral pre-screening & retention 

    With expertise in over 400 trials, 30 therapeutic areas, and over 100 conditions, Innovative Trials has established itself as a trusted and seasoned partner for pharmaceutical companies, contract research organizations (CROs) and biotechnology companies. For more information, visit www.innovativetrials.com

    Innovative Trials Ltd, Innovative House, Avenue One, Letchworth Garden City, Hertfordshire, SG6 2WW, United Kingdom

    Queen’s Award for Enterprise –  2020/2025

    Pharma Industry Awards UK 2024 – Women in Pharma Winner

    PMEA Awards Finalist, Excellence in Collaboration and Partnerships – 2024

    PMEA Awards Finalist, Support Agency of the Year – 2023 

    Lloyd’s Bank British Business Excellence Awards 2023 – Finalist

    Inspiring Hertfordshire Awards 2023 – International Trade

    Best Global Patient Recruitment Company  – 2021

    Patient Recruitment

     

    Patient recruitment company, Innovative Trials, nominated a finalist in prestigious award

    UK-based patient recruitment company celebrates an incredible achievement in a national award nomination

    Innovative Trials attended the Inspire Hertfordshire Award gala dinner

    Innovative Trials, a global clinical trial patient recruitment and retention company based in Hertfordshire, has been recognised for its contribution to the county’s economy and business reputation.

    Innovative Trials responds to national recommendations to tackle UK clinical trial decline

    Kate Shaw, Founder & CEO, comments on the Lord report of the Lord O’Shaughnessy review into commercial clinical trials in the UK.

    Innovative Trials nominates Eloise Moffett as New VP of Commercial

    Eloise Moffett joins Innovative Trials as New Vice President of Commercial to drive business growth globally

    Kate Shaw comments the appointment of an independent review on clinical trials in the UK.

    The news comes after a report by the Association of the British Pharmaceutical Industry (ABPI) highlighted a 44% decline in industry clinical trials in the UK over the last five...

    Innovative Trials comments on extra funding to increase access to clinical trials for cancer patients

    Kate Shaw, Innovative Trials' Founder & CEM, reflects on the exciting news for patients affected by cancer in the UK.

    Innovative Trials opens first US office

    The leading global patient recruitment organisation has opened its first international office in the Raleigh, North Carolina

    Innovative Trials partners with MS Society

    UK-based patient recruitment company announces its annual charity partnership in support of multiple sclerosis

    FREE Live Webinar – Accelerating Patient recruitment in Clinical Trials post COVID-19 – 8th June 2022

    Innovative Trials and Parexel invite you to attend the live webinar

    Innovative Trials named a finalist in the Inspiring Hertfordshire Awards

    The patient recruitment organisation has been shortlisted in the Inspiring Hertfordshire awards

    ALL PRESS RELEASES

    Patient Recruitment in Oncology: A Phase III Melanoma Case Study

    Boosting screening & enrollment rates in a global oncology trial

    Mastering Patient Recruitment: A Framework of Five Essential Strategies Developed Over 15 Years

    Clinical trial patient recruitment and retention practices have significantly advanced over the last 15 years thanks to technological innovations and the rise of AI, shifting patient expectations and the increased,...

    The Impact of AI on Clinical Trials: Four Key Benefits and Three Major Risks

    Artificial intelligence (AI) in clinical research has the potential to accelerate patient access to new treatments by streamlining the drug development process and helping to generate more robust data, which...

    Three Key Trends Shaping the Future of Clinical Trials

    So far this year, we have witnessed several announcements that could have a major impact on the clinical trials market and our global health overall.

    Education urgently needed to reverse lack of women-only clinical trials

    Kate Shaw, founder and CEO of Innovative Trials, has responded to data that shows the UK has far fewer women-only clinical trials compared to male-only studies. Read the full article here.

    Seven strategic steps to enhance patient recruitment & retention in your influenza studies

    The development of all treatments, including vaccines, is dependent on people taking part in clinical trials but this can be challenging for influenza studies, especially given the typically short patient...

    Movember 2024 – Men’s Health

    This Movember, Innovative Trials are raising awareness about men’s health issues like prostate cancer, testicular cancer, and mental health.

    Is your influenza clinical trial prepared for the upcoming flu season? Part 3

    This blog will discuss some important aspects to consider to maximise patient retention on your flu clinical trials. For more information on patient recruitment considerations, check out our previous blogs...

    Is your influenza clinical trial prepared for the upcoming flu season? Part 2

    Around 86% of clinical trials do not meet patient recruitment goals, ultimately failing to improve patient outcomes and resulting in financial losses for sponsors and research sites (Rangu and Maxwell,...

    Is your influenza clinical trial prepared for the upcoming flu season? Part 1

    The Northern Hemisphere flu season is fast approaching, bringing with it a multitude of challenges for respiratory clinical trials. The exact dates of the flu season in the Northern Hemisphere...

    ALL WHITE PAPERS

    Innovative Trials celebrates its 15th anniversary

    🎉 Cheers to 15 years of patient recruitment and retention innovation and impact at Innovative Trials! 🎉 From 2010 to 2025, we’ve been on an incredible journey of growth, impact,...

    Uniting Communities for Rare Disease Clinical Trial Success

    Step into the realm of innovation and collaboration in patient recruitment and retention with our upcoming webinar, "Bridging Boundaries: Uniting Communities for Rare Disease Clinical Trial Success." Delve deep into...

    Patient Recruitment & Retention Strategies in the 2024 Clinical Trial Landscape

    In the landscape of the clinical trial industry in 2024, persistent challenges persist in the realms of patient recruitment and retention. These hurdles, having endured over several years, continue to...

    Solving your biggest patient recruitment and retention challenges

    Clinical trial patient recruitment and retention remains one of the key challenges to successfully bringing a new therapeutic to market. An estimated 85% of clinical trials face delays due to...

    Retention Patch Program

    A partnership between Innovative Trials and the non-profit Oliver Patch Project to boost retention in pediatric studies

    The Navigator – Revolutionize your patient recruitment and retention

    Navigating patients step by step on their clinical trial journey

    For clinical trial participants, navigating their way through a study can sometimes seem daunting and complicated. Without the right support, around 30% are likely to drop out [1], resulting in...

    Patient Recruitment: Think Global, Act Local

    Global clinical trials are a vital component of pharma R&D. Utilizing sites in multiple countries not only provides increased access to eligible and diverse patients - and therefore more robust...

    Overcoming Patient Recruitment Challenges in Rare Disease Trials

    Rare diseases are thought to affect up to 446 million people worldwide. With more than 7,000 rare diseases, most of which are genetic, it’s vital all patients can access new...

    Innovative Trials opens first US office

    We are incredibly excited to announce the opening of our very first US office! This is an incredible milestone towards our mission to accelerate clinical development. Read the full press...

    ALL VIDEOS AND PODCASTS

    Equality and Diversity Commitment

    Innovative Trials is committed to ensuring we eliminate discrimination from all of our processes and culture. Our Equality and Diversity Committee is here to support the company in creating an organisation where the working environment is accessible, responsive and appropriate to people where all employees can fully contribute, develop and flourish at work, irrespective of their personal characteristics.

    Our commitment is to :

    • Take an overview of equality, diversity and human rights issue to support the company’s strategic agenda in this area.
    • Work within Equality and Human Rights Commission guidelines and codes of practice.
    • To oversee the design, implementation and periodic review of IT’s equality objectives.
    • To oversee the implementation, completion, monitoring, audit and evaluation of the Equality Impact Assessment (EqIA) process for policy and procedures.

    Eloise Moffett

    Eloise Moffett
    Vice President of Commercial
    eloise.moffett@innovativetrials.com
    +1 984 212 2079
    Linkedin Profile

    Laura Burt

    Laura Burt
    Director of Operations
    laura.burt@innovativetrials.com
    +44 (0) 1707 682 287
    Linkedin Profile

    Marco Lassandro

    Marco Lassandro
    Head of Marketing
    marco.lassandro@innovativetrials.com
    +44 (0) 1707 959 525
    Linkedin Profile

    Kate Shaw

    Kate Shaw
    Founder and CEO
    kate.shaw@innovativetrials.com
    +44 (0) 1707 378 581
    Linkedin Profile

    Please note – you must be logged in to X in this browser in order to see this Twitter / X Feed

    Company Details

    - PMLiVE

    Email
    Website

     Latest Content from  Innovative Trials 

    AstraZeneca and Merck decision to disinvest in the UK is a ‘tragedy’ for British research and innovation

    Kate Shaw comments on the latest news about AstraZeneca and Merck's decision to hold planned investments in the UK

    Patient Recruitment in Oncology: A Phase III Melanoma Case Study

    Boosting screening & enrollment rates in a global oncology trial

    Mastering Patient Recruitment: A Framework of Five Essential Strategies Developed Over 15 Years

    Clinical trial patient recruitment and retention practices have significantly advanced over the last 15 years thanks to technological innovations and the rise of AI, shifting patient expectations and the increased,...

    The Impact of AI on Clinical Trials: Four Key Benefits and Three Major Risks

    Artificial intelligence (AI) in clinical research has the potential to accelerate patient access to new treatments by streamlining the drug development process and helping to generate more robust data, which...

    Three Key Trends Shaping the Future of Clinical Trials

    So far this year, we have witnessed several announcements that could have a major impact on the clinical trials market and our global health overall.

    Innovative Trials names Hertfordshire hospice as 2025 UK charity partner

    Innovative Trials, an internationally renowned clinical trials patient recruitment company based in the UK, has today announced Garden House Hospice Care as its UK charity partner for 2025/26. It continues...

    Education urgently needed to reverse lack of women-only clinical trials

    Kate Shaw, founder and CEO of Innovative Trials, has responded to data that shows the UK has far fewer women-only clinical trials compared to male-only studies. Read the full article here.

    Free Live Webinar – Patient Recruitment & Retention

    Join Innovative Trials and Soglia in this new patient recruitment and retention webinar!

    Innovative Trials celebrates its 15th anniversary

    🎉 Cheers to 15 years of patient recruitment and retention innovation and impact at Innovative Trials! 🎉 From 2010 to 2025, we’ve been on an incredible journey of growth, impact,...

    Innovative Trials appoints first Non-Executive Chair

    John Watkinson is the new Non-Exec Chair as Innovative Trials targets significant business growth